Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/20/2002EP1257641A2 Method of modulating glycosylation pathways
11/20/2002EP1257639A2 Nucleozymes with endonuclease activity
11/20/2002EP1257637A2 Sphingosine kinases
11/20/2002EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002EP1257582A2 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
11/20/2002EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use
11/20/2002EP1257580A2 Human ion channels
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257577A2 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
11/20/2002EP1257576A1 Vasoactive intestinal peptide analogs
11/20/2002EP1257575A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
11/20/2002EP1257574A1 Improved interleukin 10
11/20/2002EP1257572A2 Narc-1, subtilase-like homologs
11/20/2002EP1257568A1 Novel echinocandin derivatives, preparation method and use thereof as fungicides
11/20/2002EP1257567A2 Cationic, amphipathic beta-sheet peptides and uses thereof
11/20/2002EP1257566A1 Method of treating disorders of the eye
11/20/2002EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy
11/20/2002EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method
11/20/2002EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002EP1257561A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein
11/20/2002EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002EP1257296A2 Caspase activated prodrugs therapy
11/20/2002EP1257295A2 Factor vii or viia-like molecules
11/20/2002EP1257292A1 Use of il-18 inhibitors
11/20/2002EP1257288A1 Method for regulating il-10 with il-9, and applications thereof
11/20/2002EP1257287A1 Compositions and methods for the early diagnosis of ovarian cancer
11/20/2002EP1257286A2 Cancer treatment and prognosis involving hes-1 protein
11/20/2002EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002EP1257284A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
11/20/2002EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002EP1257261A2 Antiviral pharmaceutical compositions containing iron chelators
11/20/2002EP1257260A1 Powder formulation for inhalation
11/20/2002EP1206582A4 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/20/2002EP1156759A4 Biodegradable polymeriprotein based coils for intralumenal implants
11/20/2002EP1112095B1 Biologically active implants
11/20/2002EP1098645B1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds)
11/20/2002EP1002542B1 Use of vip for the preparation of a medicament for treating the endotoxic shock in mammals
11/20/2002EP0984784B1 Anti-cancer products for treating cystic fibrosis
11/20/2002EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/20/2002EP0954326A4 A process for viral inactivation of lyophilized blood proteins
11/20/2002EP0946189B1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/20/2002EP0935469B1 Use of growth hormone
11/20/2002EP0929314B1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
11/20/2002EP0871458B1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
11/20/2002EP0852619B1 A modified glutamic acid decarboxylase (gad)
11/20/2002EP0845992B1 Use of relaxin for promoting angiogenesis
11/20/2002EP0758394B1 Bifunctional protein, preparation and use
11/20/2002EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/20/2002EP0550506B1 Novel chemotactic factor
11/20/2002CN1380813A Primary composition containing lipophilic bioactive compound
11/20/2002CN1380419A Method for preparing human interleukin 4 by using gene engineering and its expression vector and engineering bacterium
11/20/2002CN1380414A Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application
11/20/2002CN1380413A Human 6-phosphoglucosamine isomerase, its code sequence and application
11/20/2002CN1380412A A polypeptide-serine proteinase-10.12 and polynucleotide for coding this polypeptide
11/20/2002CN1380411A A polypeptide-glycosyl hydrolase-11.99 and polynucleotide for coding this polypeptide
11/20/2002CN1380410A A polypeptide-human inosine triphosphate pyrophosphate hydrolase-21.34 and polynucleotide for coding this polypeptide
11/20/2002CN1380409A A polypeptide-uridine diphosphate-galatoxyl cermaide glucuronyl collagen transferase-51.59 and polynucleotide for coding this polypeptide
11/20/2002CN1380408A A polypeptide-Glu/Leu/Phe/Val dehydrogenase-11.55 and polynucleotide for coding this polypeptide
11/20/2002CN1380407A New human-phosphoguanosine reductase, its coding sequence and application
11/20/2002CN1380406A A polypeptide-nitrous acid/sulfurous acid reductanse-9.57 and polynucleotide for coding this polypeptide
11/20/2002CN1380405A A polypeptide-tyrosinase-9.13 and polynucleotide for coding this polypeptide
11/20/2002CN1380404A A polypeptide-tyrosinase-11.22 and polynucleotide for coding this polypeptide
11/20/2002CN1380403A A polypeptide-human dioxygenase-9.24 and polynucleotide for coding this polypeptide
11/20/2002CN1380402A A polypeptide-pterin molybdenum oxide-reductase-13.76 and polynucleotide for coding this polypeptide
11/20/2002CN1380401A A polypeptide-quinoprotein dehydrogenase-12.10 and polynucleotide for coding this polypeptide
11/20/2002CN1380400A A polypeptide-hydrogenase-9.46 and polynucleotide for coding this polypeptide
11/20/2002CN1380399A A polypeptide-hydroxymethyl glutaryl coenzyme A reductase 9.35 and polynucleotide for coding this polypeptide
11/20/2002CN1380398A A polypeptide-indole-3-propanetriolphosphosynthetase-9.35 and polynucleotide for coding this polypeptide
11/20/2002CN1380397A A polypeptide-polymerized nucleoside polymerase-80.96 and polynucleotide for coding this polypeptide
11/20/2002CN1380396A A polypeptide-dihydrodipyridine synthetase-9.02 and polynucleotide for coding this polypeptide
11/20/2002CN1380395A A polypeptide-deoxyribonucleic acid polymerase-11.55 and polynucleotide for coding this polypeptide
11/20/2002CN1380394A A polypeptide-nucleoside triphosphate synthetase-9.35 and polynucleotide for coding this polypeptide
11/20/2002CN1380393A A polypeptide-adenosine triphosphatesynthetase-10.89 and polynucleotide for coding this polypeptide
11/20/2002CN1380392A Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application
11/20/2002CN1380338A Human testis specific protein -16 gene coded protein
11/20/2002CN1380312A A polypeptide-acidic secretion protein-9.35 and polynucleotide for coiding this polypeptide
11/20/2002CN1380304A N-terminal deletion lipocyte complement related protein and its preparation method
11/20/2002CN1380300A Deoxyribozymeoligonucleotide structure for inhibiting telomerase activity and its application
11/20/2002CN1380097A Growth hormone liposome for pig and its preparation method
11/20/2002CN1379989A Glycooxidase and its application in baking process
11/20/2002CN1094345C High dose liposomal aerosol formulations
11/20/2002CA2409865A1 Hypotensive and hypertensive activities from the renal medulla
11/19/2002US6484127 Oil maintenance indicator
11/19/2002US6482943 Quinones as disease therapies
11/19/2002US6482936 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/19/2002US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002US6482934 Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells
11/19/2002US6482932 Nucleoside triphosphates and their incorporation into oligonucleotides
11/19/2002US6482929 Antibodies to ARF-p19
11/19/2002US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002US6482926 Antibody compositions for preparing enriched cell preparations
11/19/2002US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002US6482923 Interleukin 17-like receptor protein
11/19/2002US6482922 Mammary transforming protein
11/19/2002US6482921 Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
11/19/2002US6482919 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/19/2002US6482864 Sustained-release preparation of physiologically active polypeptide and production thereof
1 ... 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 ... 3163